Marta Pardo1, Laura López-Cruz1, Noemí San Miguel1, John D Salamone2, Mercè Correa3,4. 1. Àrea de Psicobiologia, Campus de Riu Sec, Universitat Jaume I, 12071, Castelló, Spain. 2. Department of Psychology, University of Connecticut, Storrs, CT, 06269-1020, USA. 3. Àrea de Psicobiologia, Campus de Riu Sec, Universitat Jaume I, 12071, Castelló, Spain. correa@psb.uji.es. 4. Department of Psychology, University of Connecticut, Storrs, CT, 06269-1020, USA. correa@psb.uji.es.
Abstract
RATIONALE: Low doses of dopamine (DA) antagonists and accumbens DA depletions reduce food-reinforced instrumental behavior but do not impair primary food motivation, causing animals to reallocate behavior away from food-reinforced tasks with high response requirements and select less effortful alternatives. However, it is uncertain if this same pattern of effects would occur if sucrose was used as the reinforcer. OBJECTIVES: These experiments studied the impact of DA depletion and antagonism on performance of an effort-related choice task using sucrose as the reinforcer, as well as sucrose consumption, preference, and taste reactivity tests. METHODS: The effects of DA manipulations were assessed using a task in which rats chose between lever pressing on a fixed ratio 7 schedule for 5.0 % sucrose versus freely consuming a less concentrated solution (0.3 %). RESULTS: The DA depleting agent tetrabenazine shifted effort-related choice, decreasing lever pressing for 5.0 % sucrose but increasing intake of the concurrently available 0.3 % sucrose. Tetrabenazine did not affect sucrose appetitive taste reactivity, or sucrose consumption or preference, in free consumption tests. The D1 antagonist ecopipam and the D2 antagonist haloperidol also shifted choice behavior at doses that did not alter sucrose consumption or preference. In contrast, sucrose pre-exposure reduced consumption across all conditions. D3 antagonism had no effects. CONCLUSIONS: D1 and D2 receptor blockade and DA depletion reduce the tendency to work for sucrose under conditions that leave fundamental aspects of sucrose motivation (intake, preference, hedonic reactivity) intact. These findings have implications for studies employing sucrose intake or preference in animal models of depression.
RATIONALE: Low doses of dopamine (DA) antagonists and accumbens DA depletions reduce food-reinforced instrumental behavior but do not impair primary food motivation, causing animals to reallocate behavior away from food-reinforced tasks with high response requirements and select less effortful alternatives. However, it is uncertain if this same pattern of effects would occur if sucrose was used as the reinforcer. OBJECTIVES: These experiments studied the impact of DA depletion and antagonism on performance of an effort-related choice task using sucrose as the reinforcer, as well as sucrose consumption, preference, and taste reactivity tests. METHODS: The effects of DA manipulations were assessed using a task in which rats chose between lever pressing on a fixed ratio 7 schedule for 5.0 % sucrose versus freely consuming a less concentrated solution (0.3 %). RESULTS: The DA depleting agent tetrabenazine shifted effort-related choice, decreasing lever pressing for 5.0 % sucrose but increasing intake of the concurrently available 0.3 % sucrose. Tetrabenazine did not affect sucrose appetitive taste reactivity, or sucrose consumption or preference, in free consumption tests. The D1 antagonist ecopipam and the D2 antagonist haloperidol also shifted choice behavior at doses that did not alter sucrose consumption or preference. In contrast, sucrose pre-exposure reduced consumption across all conditions. D3 antagonism had no effects. CONCLUSIONS: D1 and D2 receptor blockade and DA depletion reduce the tendency to work for sucrose under conditions that leave fundamental aspects of sucrose motivation (intake, preference, hedonic reactivity) intact. These findings have implications for studies employing sucrose intake or preference in animal models of depression.
Authors: Allison M Mott; Eric J Nunes; Lyndsey E Collins; Russell G Port; Kelly S Sink; Jörg Hockemeyer; Christa E Müller; John D Salamone Journal: Psychopharmacology (Berl) Date: 2009-01-09 Impact factor: 4.530
Authors: James M Gold; Gregory P Strauss; James A Waltz; Benjamin M Robinson; Jamie K Brown; Michael J Frank Journal: Biol Psychiatry Date: 2013-02-07 Impact factor: 13.382
Authors: Ryan D Ward; Eleanor H Simpson; Vanessa L Richards; Gita Deo; Kathleen Taylor; John I Glendinning; Eric R Kandel; Peter D Balsam Journal: Neuropsychopharmacology Date: 2012-03-14 Impact factor: 7.853
Authors: Samantha E Yohn; Samantha L Collins; Hector M Contreras-Mora; Emily L Errante; Margaret A Rowland; Merce Correa; John D Salamone Journal: Neuropsychopharmacology Date: 2015-06-24 Impact factor: 7.853
Authors: Samantha E Yohn; Laura Lopez-Cruz; Peter H Hutson; Merce Correa; John D Salamone Journal: Psychopharmacology (Berl) Date: 2015-12-23 Impact factor: 4.530
Authors: Jen-Hau Yang; Rose E Presby; Adam A Jarvie; Renee A Rotolo; R Holly Fitch; Mercè Correa; John D Salamone Journal: Psychopharmacology (Berl) Date: 2019-08-08 Impact factor: 4.530
Authors: Renee A Rotolo; Predrag Kalaba; Vladimir Dragacevic; Rose E Presby; Julia Neri; Emily Robertson; Jen-Hau Yang; Merce Correa; Vasiliy Bakulev; Natalia N Volkova; Christian Pifl; Gert Lubec; John D Salamone Journal: Psychopharmacology (Berl) Date: 2020-08-07 Impact factor: 4.530
Authors: John D Salamone; Mercè Correa; Sarah Ferrigno; Jen-Hau Yang; Renee A Rotolo; Rose E Presby Journal: Pharmacol Rev Date: 2018-10 Impact factor: 25.468